Immunogenicity and safety of co-administered Escherichia coli-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine
Rui Yan, Mengting Cen, Yang Zhou, Liyang Ma, Xiaofei Zhou, Hanqing He, Xiaohua Qi, Xuewen Tang, Hui Liang, Yaping Chen, Jiaxing Qi, Shigui Yang · 2026
Read Immunogenicity and safety of co-administered Escherichia coli-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine by Rui Yan, Mengting Cen, Yang Zhou, Liyang Ma, Xiaofei Zhou, Hanqing He, Xiaohua Qi, Xuewen Tang, Hui Liang, Yaping Chen, Jiaxing Qi, Shigui Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13260377.txt.
Description
Rui Yan and colleagues ran in 2026 a trial testing whether two vaccines can be given together safely: a bivalent HPV vaccine and a hepatitis E vaccine. Both infections matter greatly for women of childbearing age. Their randomized trial at four sites in Zhejiang Province, China, enrolled 480 women aged 18 to 25.
Groups received both vaccines together or each one alone, on a schedule across months zero, one, and six. Every group reached full seroconversion, meaning all women mounted the target antibody response. Antibody levels in the combined group met the preset bar for being no worse than single vaccination. Most reactions were mild, and no serious event was blamed on a vaccine. The authors support giving the two together to simplify clinic visits.
Catalog record
| CREATOR | Rui Yan, Mengting Cen, Yang Zhou, Liyang Ma, Xiaofei Zhou, Hanqing He, Xiaohua Qi, Xuewen Tang, Hui Liang, Yaping Chen, Jiaxing Qi, Shigui Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |